Related Experiment Video
Updated: May 9, 2026
04:22
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Pharmacogenomics and sexuality: a vision.
1Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, IRCCS S. Matteo Foundation, Pavia, Italy.
Summary
Female sexual dysfunction (FSD) involves complex biopsychosocial factors. Understanding the genetic basis of FSD is crucial for personalized treatments, though research is limited.
Area of Science:
- Sexual medicine
- Genetics
- Pharmacogenomics
Background:
- Female sexual dysfunction (FSD) is a complex condition influenced by biological, psychological, and social factors throughout a woman's reproductive life.
- Neuroendocrine and neurovascular sexual pathways are shaped by life experiences, genetics, epigenetics, and medical conditions.
- Current understanding of FSD lacks sufficient research into its genetic underpinnings and the interplay of various modulating factors.
Purpose of the Study:
- To highlight the need for understanding the genetic basis of FSD.
- To emphasize the potential of pharmacogenomics in tailoring treatments for women with FSD.
- To underscore the current limitations in research regarding genetic contributions to FSD.
Main Methods:
- Review of existing literature on FSD, genetics, and pharmacogenomics.
- Analysis of the interplay between biopsychosocial factors and sexual response.
- Identification of research gaps in the genetic etiology of FSD.
Main Results:
- FSD is multidimensional, influenced by a complex interplay of factors across the reproductive lifespan.
- There is a significant paucity of studies investigating the genetic contribution to FSD.
- Pharmacogenomic data related to sexual dysfunction primarily originates from male subjects.
Conclusions:
- Understanding the genetic basis of FSD is essential for identifying clinical phenotypes and optimizing interventions.
- Pharmacogenomics holds promise for personalized medical practice in women with FSD, predicting treatment efficacy and side effects.
- Further research is needed to explore the genetic and epigenetic factors influencing female sexual response and distress.
Related Concept Videos
01:29Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:27Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
01:21Pharmacodynamics: Overview and Principles
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or within...